Renfeng Guo is currently serving as the CSO and Co-Founder at InflaRx Gmbh since January 2008. Previously, Renfeng has been an Adjunct Associate Professor at the University of Michigan Medical School since February 1998. Renfeng holds a Post-doc degree in Inflammation & immunology from the University of Michigan Medical School, an M.D. in Oncology from Norman Bethune University of Medical Sciences, and an M.S. in Cancer Immunology from Beijing Institute of Radiation Medicine.
Current role
Chief Scientific Officer & Founder at AbFero Pharmaceuticals
Chief Scientific Officer & Founder at AXONIS Therapeutics
Chief Scientific Officer & Founder at Arrien Pharmaceuticals
Chief Scientific Officer & Founder at Concentric Analgesics
Chief Scientific Officer & Founder at Waveguide